Intrust Bank NA Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Intrust Bank NA lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,258 shares of the healthcare conglomerate’s stock after purchasing an additional 182 shares during the quarter. Intrust Bank NA’s holdings in UnitedHealth Group were worth $5,401,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the business. Robbins Farley bought a new stake in shares of UnitedHealth Group during the 3rd quarter valued at about $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $26,000. CGC Financial Services LLC grew its stake in shares of UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC lifted its holdings in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA lifted its holdings in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

UNH has been the topic of several recent research reports. Barclays upped their price objective on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective on the stock in a research report on Thursday, April 4th. Morgan Stanley cut their price objective on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Bank of America reissued a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Finally, Royal Bank of Canada decreased their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Stock Down 1.3 %

Shares of NYSE:UNH traded down $6.32 on Monday, hitting $489.03. 2,192,065 shares of the company’s stock were exchanged, compared to its average volume of 4,469,341. The company has a market capitalization of $449.95 billion, a PE ratio of 30.02, a P/E/G ratio of 1.43 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The firm’s 50-day moving average is $485.84 and its 200 day moving average is $514.07.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the prior year, the business earned $6.26 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s payout ratio is 45.97%.

Insider Activity at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.